<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01391364</url>
  </required_header>
  <id_info>
    <org_study_id>691</org_study_id>
    <nct_id>NCT01391364</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate a Modified Contact Lens</brief_title>
  <official_title>A Study to Evaluate the Product Performance of a Modified Contact Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bausch &amp; Lomb Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bausch &amp; Lomb Incorporated</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is being conducted to evaluate the product performance of SofLens daily disposable&#xD;
      contact lenses packaged in an investigational Test solution versus SofLens daily disposable&#xD;
      contact lenses packaged in the currently marketed solution (Control), as it relates to&#xD;
      comfort when worn by adapted soft contact lens wearers on a daily-wear basis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Eyes With &gt; Grade 2 Slit Lamp Findings</measure>
    <time_frame>At 2 weeks follow up</time_frame>
    <description>Graded slit lamp findings for each eye, including epithelial edema, epithelial microcysts, corneal staining, limbal and bulbar injections, upper lid tarsal conjunctival abnormalities, corneal neovascularization, and corneal infiltrates were graded for severity on a scale from 0 (No Finding) to 4 (Severe Finding). The outcome measure is any finding &gt; grade 2, across abnormalities.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Acuity</measure>
    <time_frame>At 2 weeks follow up</time_frame>
    <description>Visual acuity was assessed by distance high contrast logarithm of the minimum angle of resolution (logMAR).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Symptoms and Complaints</measure>
    <time_frame>At 2 weeks follow up</time_frame>
    <description>Symptoms and complaints were assessed on a scale from 0 to 100, with 0 denoting the most unfavorable symptoms/complaints. Symptoms/complaints were collected by eye from each participant and based on the participant's experience with the study lenses. Symptoms/complaints parameters included the following: Burning/stinging upon insertion, Comfort upon insertion, Overall comfort, Comfort at end of day, Ease of handling/insertion, Ease of handling/removal, Dryness, Itchiness, Redness, Vision upon insertion, Vision, Vision in low light, Lens cleanness upon insertion, Lens cleanness upon removal, and Overall impression.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">438</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>SofLens in investigational solution</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bausch + Lomb SofLens daily disposable contact lens packaged in an investigational storage solution.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SofLens in currently marketed solution</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>SofLens daily disposable contact lens packaged in currently marketed storage solution.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SofLens in investigational solution</intervention_name>
    <description>SofLens in investigational solution, worn on a daily disposable basis for 7 days.</description>
    <arm_group_label>SofLens in investigational solution</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SofLens in currently marketed solution</intervention_name>
    <description>SofLens packaged in currently marketed solution, worn on a daily disposable basis for 7 days.</description>
    <arm_group_label>SofLens in currently marketed solution</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects must be free of any anterior segment disorders.&#xD;
&#xD;
          -  Subjects must be adapted lens wearers and wear a lens in each eye and each lens must&#xD;
             be of the same manufacture and brand.&#xD;
&#xD;
          -  Subjects must be myopic and require contact lens correction from -0.50 D to -6.00 D in&#xD;
             each eye.&#xD;
&#xD;
          -  Subjects must be habitual wearers of daily disposable or planned replacement (at least&#xD;
             every 3 months) soft contact lenses.&#xD;
&#xD;
          -  Subjects must live/work in an urban environment at least 6 hours per day and for at&#xD;
             least 4 days per week throughout the duration of the study.&#xD;
&#xD;
          -  Subjects must be willing and able to wear the study lenses on a daily wear basis while&#xD;
             in an urban environment.&#xD;
&#xD;
          -  Subjects living/working in the urban environment must feel challenged by harsh, drying&#xD;
             outdoor conditions (ie dust, pollution, smog).&#xD;
&#xD;
          -  Subjects must feel that being in an urban environment has a negative effect on their&#xD;
             lens wearing experience.&#xD;
&#xD;
          -  Subjects must have access to an internet connection and be able to send and receive&#xD;
             email.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects who have worn gas permeable (GP) contact lenses within the last 30 days or&#xD;
             who have worn polymethylmethacrylate (PMMA) lenses within the last three months.&#xD;
&#xD;
          -  Subjects with any systemic disease currently affecting ocular health or which in the&#xD;
             Investigator's opinion may have an effect on ocular health during the course of the&#xD;
             study.&#xD;
&#xD;
          -  Subjects using any systemic or topical medications that will, in the Investigator's&#xD;
             opinion, affect ocular physiology or lens performance.&#xD;
&#xD;
          -  Subjects with an active ocular disease or who are using any ocular medication.&#xD;
&#xD;
          -  Subjects with any grade 2 or greater finding during the slit lamp examination&#xD;
&#xD;
          -  Subjects with any &quot;Present&quot; finding during the slit lamp examination that, in the&#xD;
             Investigator's judgment, interferes with contact lens wear.&#xD;
&#xD;
          -  Subjects with any scar or neovascularization within the central 4 mm of the cornea.&#xD;
             Subjects with minor peripheral corneal scarring (that does not extend into the central&#xD;
             area), that in the Investigator's judgment, does not interfere with contact lens wear,&#xD;
             are eligible for this study.&#xD;
&#xD;
          -  Subjects who are allergic to any component in the study care products.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Bausch &amp; Lomb, Inc.</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14609</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>June 16, 2011</study_first_submitted>
  <study_first_submitted_qc>July 8, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 12, 2011</study_first_posted>
  <results_first_submitted>August 21, 2020</results_first_submitted>
  <results_first_submitted_qc>September 9, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 30, 2020</results_first_posted>
  <last_update_submitted>September 9, 2020</last_update_submitted>
  <last_update_submitted_qc>September 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ocular irritation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>There were 438 eligible participants (876 eyes) enrolled.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>SofLens in Investigational Solution</title>
          <description>Bausch + Lomb SofLens daily disposable contact lens packaged in an investigational storage solution.&#xD;
SofLens in investigational solution: SofLens in investigational solution, worn on a daily disposable basis for 7 days.</description>
        </group>
        <group group_id="P2">
          <title>SofLens in Currently Marketed Solution</title>
          <description>SofLens daily disposable contact lens packaged in currently marketed storage solution.&#xD;
SofLens in currently marketed solution: SofLens packaged in currently marketed solution, worn on a daily disposable basis for 7 days.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="222"/>
                <participants group_id="P2" count="216"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="217"/>
                <participants group_id="P2" count="214"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Demographics were reported for all dispensed, eligible participants, 222 in the investigational group and 215 in the control group.</population>
      <group_list>
        <group group_id="B1">
          <title>SofLens in Investigational Solution</title>
          <description>Bausch + Lomb SofLens daily disposable contact lens packaged in an investigational storage solution.&#xD;
SofLens in investigational solution: SofLens in investigational solution, worn on a daily disposable basis for 7 days.</description>
        </group>
        <group group_id="B2">
          <title>SofLens in Currently Marketed Solution</title>
          <description>SofLens daily disposable contact lens packaged in currently marketed storage solution.&#xD;
SofLens in currently marketed solution: SofLens packaged in currently marketed solution, worn on a daily disposable basis for 7 days.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="222"/>
            <count group_id="B2" value="215"/>
            <count group_id="B3" value="437"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.9" lower_limit="18" upper_limit="40"/>
                    <measurement group_id="B2" value="27.2" lower_limit="18" upper_limit="40"/>
                    <measurement group_id="B3" value="27.6" lower_limit="18" upper_limit="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="164"/>
                    <measurement group_id="B2" value="146"/>
                    <measurement group_id="B3" value="310"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="58"/>
                    <measurement group_id="B2" value="69"/>
                    <measurement group_id="B3" value="127"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Eyes With &gt; Grade 2 Slit Lamp Findings</title>
        <description>Graded slit lamp findings for each eye, including epithelial edema, epithelial microcysts, corneal staining, limbal and bulbar injections, upper lid tarsal conjunctival abnormalities, corneal neovascularization, and corneal infiltrates were graded for severity on a scale from 0 (No Finding) to 4 (Severe Finding). The outcome measure is any finding &gt; grade 2, across abnormalities.</description>
        <time_frame>At 2 weeks follow up</time_frame>
        <population>Dispensed eyes with nonmissing scores in each treatment group are included in the analysis population.</population>
        <group_list>
          <group group_id="O1">
            <title>SofLens in Investigational Solution</title>
            <description>Bausch + Lomb SofLens daily disposable contact lens packaged in an investigational storage solution.&#xD;
SofLens in investigational solution: SofLens in investigational solution, worn on a daily disposable basis for 7 days.</description>
          </group>
          <group group_id="O2">
            <title>SofLens in Currently Marketed Solution</title>
            <description>SofLens daily disposable contact lens packaged in currently marketed storage solution.&#xD;
SofLens in currently marketed solution: SofLens packaged in currently marketed solution, worn on a daily disposable basis for 7 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Eyes With &gt; Grade 2 Slit Lamp Findings</title>
          <description>Graded slit lamp findings for each eye, including epithelial edema, epithelial microcysts, corneal staining, limbal and bulbar injections, upper lid tarsal conjunctival abnormalities, corneal neovascularization, and corneal infiltrates were graded for severity on a scale from 0 (No Finding) to 4 (Severe Finding). The outcome measure is any finding &gt; grade 2, across abnormalities.</description>
          <population>Dispensed eyes with nonmissing scores in each treatment group are included in the analysis population.</population>
          <units>eyes</units>
          <param>Count of Units</param>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="218"/>
                <count group_id="O2" value="215"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="436"/>
                <count group_id="O2" value="430"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Visual Acuity</title>
        <description>Visual acuity was assessed by distance high contrast logarithm of the minimum angle of resolution (logMAR).</description>
        <time_frame>At 2 weeks follow up</time_frame>
        <population>Eyes assessed for visual acuity at the 2 week follow up visit are included in the analysis population.</population>
        <group_list>
          <group group_id="O1">
            <title>SofLens in Investigational Solution</title>
            <description>Bausch + Lomb SofLens daily disposable contact lens packaged in an investigational storage solution.&#xD;
SofLens in investigational solution: SofLens in investigational solution, worn on a daily disposable basis for 7 days.</description>
          </group>
          <group group_id="O2">
            <title>SofLens in Currently Marketed Solution</title>
            <description>SofLens daily disposable contact lens packaged in currently marketed storage solution.&#xD;
SofLens in currently marketed solution: SofLens packaged in currently marketed solution, worn on a daily disposable basis for 7 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Acuity</title>
          <description>Visual acuity was assessed by distance high contrast logarithm of the minimum angle of resolution (logMAR).</description>
          <population>Eyes assessed for visual acuity at the 2 week follow up visit are included in the analysis population.</population>
          <units>logMAR</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="203"/>
                <count group_id="O2" value="200"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="406"/>
                <count group_id="O2" value="400"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.051" spread="0.062"/>
                    <measurement group_id="O2" value="-0.046" spread="0.061"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Symptoms and Complaints</title>
        <description>Symptoms and complaints were assessed on a scale from 0 to 100, with 0 denoting the most unfavorable symptoms/complaints. Symptoms/complaints were collected by eye from each participant and based on the participant's experience with the study lenses. Symptoms/complaints parameters included the following: Burning/stinging upon insertion, Comfort upon insertion, Overall comfort, Comfort at end of day, Ease of handling/insertion, Ease of handling/removal, Dryness, Itchiness, Redness, Vision upon insertion, Vision, Vision in low light, Lens cleanness upon insertion, Lens cleanness upon removal, and Overall impression.</description>
        <time_frame>At 2 weeks follow up</time_frame>
        <population>Eyes assessed for symptoms/complaints at the 2 week follow up visit are included in the analysis population.</population>
        <group_list>
          <group group_id="O1">
            <title>SofLens in Investigational Solution</title>
            <description>Bausch + Lomb SofLens daily disposable contact lens packaged in an investigational storage solution.&#xD;
SofLens in investigational solution: SofLens in investigational solution, worn on a daily disposable basis for 7 days.</description>
          </group>
          <group group_id="O2">
            <title>SofLens in Currently Marketed Solution</title>
            <description>SofLens daily disposable contact lens packaged in currently marketed storage solution.&#xD;
SofLens in currently marketed solution: SofLens packaged in currently marketed solution, worn on a daily disposable basis for 7 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Symptoms and Complaints</title>
          <description>Symptoms and complaints were assessed on a scale from 0 to 100, with 0 denoting the most unfavorable symptoms/complaints. Symptoms/complaints were collected by eye from each participant and based on the participant's experience with the study lenses. Symptoms/complaints parameters included the following: Burning/stinging upon insertion, Comfort upon insertion, Overall comfort, Comfort at end of day, Ease of handling/insertion, Ease of handling/removal, Dryness, Itchiness, Redness, Vision upon insertion, Vision, Vision in low light, Lens cleanness upon insertion, Lens cleanness upon removal, and Overall impression.</description>
          <population>Eyes assessed for symptoms/complaints at the 2 week follow up visit are included in the analysis population.</population>
          <units>score on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="217"/>
                <count group_id="O2" value="213"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="434"/>
                <count group_id="O2" value="426"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Burning/stinging upon insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83.2" spread="20.5"/>
                    <measurement group_id="O2" value="86.8" spread="20.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Comfort upon insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.2" spread="20.4"/>
                    <measurement group_id="O2" value="82.7" spread="20.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall comfort</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.6" spread="21.0"/>
                    <measurement group_id="O2" value="79.9" spread="20.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Comfort at end of day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70.3" spread="23.8"/>
                    <measurement group_id="O2" value="70.5" spread="23.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ease of handling/insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73.1" spread="24.1"/>
                    <measurement group_id="O2" value="76.3" spread="24.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ease of handling/removal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.1" spread="16.2"/>
                    <measurement group_id="O2" value="87.9" spread="16.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dryness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.2" spread="24.2"/>
                    <measurement group_id="O2" value="74.5" spread="24.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Itchiness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.5" spread="19.1"/>
                    <measurement group_id="O2" value="87.7" spread="19.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Redness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.3" spread="17.4"/>
                    <measurement group_id="O2" value="89.2" spread="17.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vision upon insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.7" spread="14.4"/>
                    <measurement group_id="O2" value="89.2" spread="14.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vision</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.7" spread="14.2"/>
                    <measurement group_id="O2" value="88.7" spread="14.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vision in low light</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85.4" spread="14.6"/>
                    <measurement group_id="O2" value="86.7" spread="14.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lens cleanness upon insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.2" spread="14.2"/>
                    <measurement group_id="O2" value="91.3" spread="14.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lens cleanness upon removal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.6" spread="15.5"/>
                    <measurement group_id="O2" value="84.1" spread="15.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall impression</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73.7" spread="21.2"/>
                    <measurement group_id="O2" value="75.9" spread="21.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 weeks</time_frame>
      <desc>Adverse events were not coded. Therefore, source vocabulary is not applicable. There were 444 eyes dispensed test lenses and 432 eyes dispensed control lenses, assessed for adverse events.</desc>
      <group_list>
        <group group_id="E1">
          <title>SofLens in Investigational Solution</title>
          <description>Bausch + Lomb SofLens daily disposable contact lens packaged in an investigational storage solution.&#xD;
SofLens in investigational solution: SofLens in investigational solution, worn on a daily disposable basis for 7 days.</description>
        </group>
        <group group_id="E2">
          <title>SofLens in Currently Marketed Solution</title>
          <description>SofLens daily disposable contact lens packaged in currently marketed storage solution.&#xD;
SofLens in currently marketed solution: SofLens packaged in currently marketed solution, worn on a daily disposable basis for 7 days.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="222"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="216"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="222"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="216"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Contact sponsor directly for details.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Study Director</name_or_title>
      <organization>Bausch Health</organization>
      <email>robert.steffen@bausch.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

